OVERCOMING MULTIPLE MYELOMA DRUG RESISTANCE IN THE ERA OF CANCER “OMICS”

Multiple myeloma (MM) is amongst the most compelling examples of cancer in which research has markedly improved the length and quality of lives of those afflicted. Research efforts have led to 18 newly approved treatments over the last 12 years, including 7 in 2015. However, despite significant impr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Leuk Lymphoma
Main Authors: Guang, Matthew Ho Zhi, McCann, Amanda, Bianchi, Giada, Zhang, Li, Dowling, Paul, Bazou, Despina, O’Gorman, Peter, Anderson, Kenneth C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6152877/
https://ncbi.nlm.nih.gov/pubmed/28610537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2017.1337115
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados